ARCHIVES

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

This article is from The Cancer Letter archive.

Vol. 01 No. 20 | June 21, 1974

Download PDF Visit The Full Archive

Related Articles

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

April 13, 2007

Bishop: Cells, Genes Reveal Unified Strategy For Cancer Conquest

March 3, 1995

As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study

November 21, 2014

Report Tells NCI to Increase Funding for SPOREs.

June 30, 2006

Prominent Duke Scientist Claimed Prizes He Didn’t Win, Including Rhodes Scholarship

July 16, 2010

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009